Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy
Authors:
- Danilo NegliaDNDanilo Neglia
- Renata De MariaRMRenata De Maria
- Stefano MasiSMStefano Masi
- Michela GallopinMGMichela Gallopin
- Patrizia PisaniPPPatrizia Pisani
- Silvia PardiniSPSilvia Pardini
- Antonello GavazziAGAntonello Gavazzi
- Antonio L’aBbateALAntonio L’aBbate
- Oberdan ParodiOPOberdan Parodi
Abstract
Objective: To assess whether chronic treatment with carvedilol can increase myocardial blood flow (MBF) and MBF reserve in idiopathic dilated cardiomyopathy (IDC). Study design: In a double-blind, placebo-controlled trial, 16 consecutive patients with IDC were randomised to treatment with either carvedilol up to 25 mg twice a day (n = 8, 7 men, mean (SD) age 60 (9) years, mean (SD) left ventricular ejection fraction (LVEF) 30% (5%)), or placebo (n = 8, 6 men, mean (SD) age 62 (9) years, mean (SD) LVEF 28% (6%), NS vs carvedilol group). Before and 6 months after treatment, regional MBF was measured at rest and after intravenous injection of dipyridamole (Dip; 0.56 mg/kg in 4 min) by positron emission tomography and using 13N-ammonia as a flow tracer. Exercise capacity was assessed as the time duration in a maximal bicycle exercise stress test. Results: Carvedilol induced a significant decrease in heart rate at rest and during maximal exercise, and an increase in exercise capacity. Absolute MBF values did not significantly change after carvedilol or placebo treatment, either at rest or during Dip injection, although Dip-MBF tended to improve after treatment. Coronary flow reserve significantly increased following carvedilol treatment (from 1.67 (0.63) to 2.58 (1.04), pConclusions: Long-term treatment with carvedilol can significantly increase coronary flow reserve and reduce the occurrence of stress-induced perfusion defects, suggesting a favourable effect of the drug on coronary microvascular function in patients with IDC.Keywords
This publication has 25 references indexed in Scilit:
- Long-Term Effects of Carvedilol or Metoprolol on Left Ventricular Function in Ischemic and Nonischemic CardiomyopathyThe American Journal of Cardiology, 2005
- Prognostic Role of Myocardial Blood Flow Impairment in Idiopathic Left Ventricular DysfunctionCirculation, 2002
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- The Effects of β 1 -Blockade on Oxidative Metabolism and the Metabolic Cost of Ventricular Work in Patients With Left Ventricular DysfunctionCirculation, 2000
- Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathyJACC, 2000
- Myocardial Blood Flow Response to Pacing Tachycardia and to Dipyridamole Infusion in Patients With Dilated Cardiomyopathy Without Overt Heart FailureCirculation, 1995
- Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathyJACC, 1994
- Vasodilatory Action of CarvedilolJournal of Cardiovascular Pharmacology, 1992
- Identifying and measuring severity of coronary artery stenosis. Quantitative coronary arteriography and positron emission tomography.Circulation, 1988
- The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathyAmerican Heart Journal, 1983